Epidermal Growth Factor Receptor (EGFR) Kinase Inhibitors and Non-Small Cell Lung Cancer (NSCLC) – Advances in Molecular Diagnostic Techniques to Facilitate Targeted Therapy
Crossref DOI link: https://doi.org/10.1007/s12253-017-0377-1
Published Online: 2017-12-21
Published Print: 2018-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Ghafoor, Qamar https://orcid.org/0000-0002-9797-1932
Baijal, Shobhit
Taniere, Phillipe
O’Sullivan, Brendan
Evans, Matthew
Middleton, Gary
Funding for this research was provided by:
Boehringer Ingelheim (UK) (N/A)
License valid from 2017-12-21